PGR and breast ductal adenocarcinoma: Crobeddu et al. demonstrated that DEHP and its primary metabolite mono (2-ethylhexyl) phthalate (MEHP) enhance the proliferation of human breast ductal carcinoma cells via upregulation of progesterone receptor (PR) [55].